Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions

American Journal Geriatric Pharmacotherapy

Volumn 3, Issue 2, 2005, Pages 65-76

  Malone, Daniel C ^a   Abarca, Jacob ^a   Hansten, Philip D ^b   Grizzle, Amy J ^a   Armstrong, Edward P ^a   Van Bergen, Robin C ^c   Duncan Edgar, Babette S ^c   Solomon, Steven L ^d   Lipton, Richard B ^e  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Innovative Medical Research   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Drug utilization review; Drug drug interactions; Medication errors; Patients safety

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFUNGAL AGENT; CARBAMAZEPINE; CLARITHROMYCIN; CYCLOSPORIN; DEXTROPROPOXYPHENE; DIGOXIN; DILTIAZEM; FLUOXETINE; FLUVOXAMINE; HEPARIN; LEVODOPA; MACROLIDE; MEVINOLIN; MONOAMINE OXIDASE INHIBITOR; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PIMOZIDE; POTASSIUM; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SIMVASTATIN; THEOPHYLLINE; TRIAZOLAM; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

COMPUTER PROGRAM; COMPUTER SYSTEM; CONSENSUS; DRUG INFORMATION; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL EXPERT; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PHARMACIST; PHARMACY; PHYSICIAN; PRIORITY JOURNAL; PUBLICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; STANDARDIZATION; SYSTEMATIC REVIEW; UNITED STATES;

EID: 23944522513     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2005.05.001     Document Type: Note

References (35)

1. National Academy of Sciences Institute of Medicine To err is human 1999 National Academy Press Washington, DC
2. Johnson JA Bootman JL Drug-related morbidity and mortality. A cost-of-illness model Arch Intern Med 155 1995 1949-1956
3. Ernst FR Grizzle AJ Drug-related morbidity and mortality: Updating the cost-of-illness model J Am Pharm Assoc 41 2001 192-199
4. Anonymous IMS health reports 14.9 percent growth in US prescription sales to $145 billion in 2000 [news release] 2001 IMS Health Fairfield, Conn.
5. Phillips DP Christenfeld N Glynn LM Increase in US medication-error deaths between 1983 and 1993 Lancet 351 1998 643-644
6. Shad MU Marsh C Preskorn SH The economic consequences of a drug-drug interaction J Clin Psychopharmacol 21 2001 119-120
7. Chrischilles EA Fulda TR Byrns PJ et al. The role of pharmacy computer systems in preventing medication errors J Am Pharm Assoc 42 2001 439-448
8. Hazlet TK Lee TA Hansten PD Horn JR Performance of community pharmacy drug interaction software J Am Pharm Assoc 41 2001 200-204
9. Chui MA Rupp MT Evaluation of online prospective DUR programs in community pharmacy practice J Manag Care Pharm 6 2000 27-32
10. Harman AJ Collecting and analyzing expert group judgment data 1975 RAND Corporation Santa Monica, Calif.
11. Abarca J Malone DC Armstrong EP et al. Concordance of major drug interaction classifications among drug interaction compendia J Am Pharm Assoc 44 2004 136-141
12. Evaluations of drug interactions 2001 First DataBank, The Hearst Corporation St. Louis, Mo.
13. Drug interaction facts 2001 Facts and Comparisons St. Louis, Mo.
14. Hansten PD Horn JR Drug interactions: Analysis and management 2001 Facts and Comparisons St. Louis, Mo.
15. DRUG-REAX system 2001 MICROMEDEX Greenwood Village, Colo.
16. Roberts JS Watrous ML Schulz RM et al. Quantifying the clinical significance of drug-drug interactions: Scaling pharmacists' perceptions of a common interaction classification scheme Ann Pharmacother 30 1996 926-934
17. Shrout PE Fleiss JL Intraclass correlations: Uses in assessing rater reliability Psychol Bull 86 1979 420-428
18. Rodrigues AD Lin JH Screening of drug candidates for their drug-drug interaction potential Curr Opin Chem Biol 5 2001 396-401
19. Marroum PJ Uppoor RS Parmelee T et al. In vivo drug-drug interaction studies - a survey of all new molecular entities approved from 1987 to 1997 Clin Pharmacol Ther 68 2000 280-285
20. Huang SM Lesko LJ Williams RL Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: Study design and data analysis issues J Clin Pharmacol 39 1999 1006-1014
21. Fulda TR Valuck RJ Vander Zanden J et al. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions Curr Ther Res 61 2000 540-548
22. Weideman RA Bernstein IH McKinney WP Pharmacist recognition of potential drug interactions Am J Health Syst Pharm 56 1999 1524-1529
23. Glassman PA Simon B Belperio P Lanto A Improving recognition of drug interactions: Benefits and barriers to using automated drug alerts Med Care 40 2002 1161-1171
24. Juurlink DN Mamdani M Kopp A et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity JAMA 289 2003 1652-1658
25. Schiff GD Computerized prescriber order entry: Models and hurdles Am J Health Syst Pharm 59 2002 1456-1460
26. Institute for Safe Medication Practices A call to eliminate handwritten prescription within 3 years [report] 2000 Institute for Safe Medication Practices Huntingdon Valley, Pa. 1-12
27. Manasse HR Medication use in an imperfect world: Drug misadventuring as an issue of public policy. Part 2 Am J Hosp Pharm 46 1989 1141-1152
28. Manasse HR Medication use in an imperfect world: Drug misadventuring as an issue of public policy. Part 1 Am J Hosp Pharm 46 1989 929-944
29. Soumerai SB Lipton HL Computer-based drug-utilization review - risk, benefit, or boondoggle? N Engl J Med 332 1995 1641-1645
30. Bates DW Leape LL Cullen DJ et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors JAMA 280 1998 1311-1316
31. Evans RS Pestotnik SL Classen DC et al. A computer assisted management program for antibiotics and other antiinfective agents N Engl J Med 338 1998 232-238
32. Armstrong EP Chrischilles EA Electronic prescribing and monitoring are needed to improve drug use Arch Intern Med 160 2000 2713-2714
33. Venot A Electronic prescribing for the elderly: Will it improve medication usage? Drugs Aging 15 1999 77-80
34. Lyles A Zuckerman IH DeSipio SM Fulda T When warnings are not enough: Primary prevention through drug use review Health Aff 17 1998 175-183
35. Knijff-Dutmer EA Schut GA van de Laar MA Concomitant coumarin-NSAID therapy and risk for bleeding Ann Pharmacother 37 2003 12-16